PipelinePharma Logo
PipelinePharma Logo
Marketplace
Sign in Get started

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-076 manufacturers

Filters

None products found

pp-076

Tablets

Dossier type
US CTD
Dossier status
Under development
Country of origin
United States
GMP approvals
FDA, Israel
Comments
Indication: Osteoporosis requiring anabolic bone-building therapy, particularly in patients at high risk of fractures or inadequate response to antiresorptive agents. Clinical stage: Phase 2 clinical development. Modality: Peptide therapeutic (oral PTH 1-34) Mechanism / Target: Oral formulation of parathyroid hormone (PTH 1-34), designed to stimulate osteoblast activity, increase bone formation, and improve bone mineral density via intermittent PTH signaling. Route / form: Oral tablets Differentiation: First potential oral anabolic PTH therapy offering an alternative to daily injections; aims to improve adherence and expand accessibility of bone-building therapy in osteoporosis.
Manufacturer #38618

A clinical-stage biopharmaceutical company developing oral peptide and protein replacement therapies to transform standards of care in chronic metabolic and rare diseases. It leverages a proprietary oral delivery platform to advance first-in-class tablet programs with global strategic development goals. The organization progresses multiple clinical programs from Phase 2 toward Phase 3 readiness.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.